Observational disease registry study to collect the data on management of LDL-Cholesterol for patients receiving lipid-modifying treatments in real-life
Not Applicable
Completed
- Conditions
- Health Condition 1: null- hypercholesterolaemia
- Registration Number
- CTRI/2018/11/016373
- Lead Sponsor
- Sanofi Synthelabo India Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 2013
Inclusion Criteria
1. Patient receiving a lipid-modifying therapy for atleast 3 months with a LDL-C value performed less than 12 months AND under the same lipid-modifying treatment (same drugs, same doses) received for at least 3 months at the time of sample
2. Patient agrees to participate in the study by giving written informed consent.
Exclusion Criteria
1.Patient currently participating in a clinical trial
2.Past use of a PCSK9 inhibitor within 6 months prior to study entry
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method